InteRNA Technologies aspires to improve cancer therapy effectiveness through innovative, intelligent miRNA-based therapeutics.
InteRNA is a Dutch biotechnology company specializing in the development of RNA therapeutics for the treatment of cancer. InteRNA is a true pioneer in the discovery and creation of a new class of drugs, called microRNAs (miRNAs). Our proprietary technology platform has been developed for discovery and validation of miRNA-based drug candidates for the simultaneous regulation of multiple targets. With this approach, we address the need for novel therapeutics with higher efficacy and less drug resistance that really benefit patients.